BOPW
CVS icon

Brandywine Oak Private Wealth’s CVS Health CVS Stock Holding History

Brandywine Oak Private Wealth’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,654
Closed -$451K – 231
2024
Q1 		$451K Hold
5,654
– – 0.05% 157
2023
Q4 		$446K Sell
5,654
-808
-13% -$57.5K 0.05% 158
2023
Q3 		$451K Sell
6,462
-370
-5% -$26.2K 0.05% 151
2023
Q2 		$472K Sell
6,832
-1,000
-13% -$71.2K 0.05% 158
2023
Q1 		$582K Sell
7,832
-200
-2% -$16.8K 0.07% 144
2022
Q4 		$748K Buy
8,032
+1
+0% +$96 0.09% 121
2022
Q3 		$765K Buy
8,031
+100
+1% +$9.9K 0.1% 115
2022
Q2 		$734K Sell
7,931
-67
-0.8% -$6.54K 0.09% 132
2022
Q1 		$809K Buy
7,998
+9
+0.1% +$945 0.09% 148
2021
Q4 		$824K Buy
7,989
+200
+3% +$18.5K 0.09% 154
2021
Q3 		$661K Buy
7,789
+301
+4% +$25.2K 0.08% 168
2021
Q2 		$624K Buy
+7,488
New +$613K 0.07% 172
2019
Q1 		– Sell
-91
Closed -$5K – 299
2018
Q4 		$5K Buy
+91
New +$6.79K ﹤0.01% 558

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Brandywine Oak Private Wealth's CVS Position: Q2 2024 in Review

Brandywine Oak Private Wealth sold out of CVS Health (CVS) in Q2 2024, closing a stake of 5,654 shares — an estimated $451K sold.

Brandywine Oak Private Wealth first reported a position in CVS in Q4 2018 and held it in 13 quarters. The position peaked at $824K in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Brandywine Oak Private Wealth reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Brandywine Oak Private Wealth sold 5,654 CVS Health shares in Q2 2024, an estimated $451K.
  • Brandywine Oak Private Wealth first reported a position in CVS Health in Q4 2018 and held it in 13 quarters.
  • Brandywine Oak Private Wealth's CVS Health position peaked at $824K in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Brandywine Oak Private Wealth's 13F filing for Q2 2024, filed 30 Jul 2024.